<DOC>
	<DOC>NCT02427009</DOC>
	<brief_summary>The main objective of this study is to assess the rate of recurrence of headache following a first blood patch where patients will be positioned in the prone position for an hour after each blood patch needed during this study.</brief_summary>
	<brief_title>Maintaining a Prone Position After Use of an Epidural Blood Patch for the Treatment of Post-dural Puncture Headache</brief_title>
	<detailed_description>The secondary objectives of this study are to: A. To evaluate the number of blood patches needed for each patient during her hospital stay B. Assessing the intensity of all headaches every 24H C. Evaluate the complications occurring during the hospital stay.</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Post-Dural Puncture Headache</mesh_term>
	<criteria>The patient was informed about the implementation of the study, its objectives, constraints and patient rights The patient has signed the informed consent The patient must be affiliated or beneficiary of a health insurance plan The patient is available for follow up concerning her hospital stay The patient has a postdural puncture headache after a vaginal delivery. The diagnosis of postpuncture headache is retained on the basis of a frankly postural character for the headache, triggered or exacerbated by orthostatic position and relieved by recumbency. The patient has an indication for a blood patch The patient is participating in another interventional study, with the exception of the following studies: Papillo PMA (2013A0053837); DGPostpartum (2013A0027738); ElastoMAP (2013A0114837); ElastoDÃ©clench (2014A0082839); LXRs(2009A0096849); OASIS II (2013A0077342); GrossPath (2014A0112047). The patient is in an exclusion period determined by a previous study The patient is under guardianship, curatorship or under judicial protection The patient refuses to sign the consent It is not possible correctly inform the patient The patient is pregnant The patient has a contraindication (or an incompatible combination therapy) for a necessary treatment in this study The patient was delivered by cesarean section</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>